Implantable cardiac devices play a significant role in decreasing the morbidity and mortality in patients with cardiovascular disease. Tissue-device interactions leading to systemic ...

Such techniques can be automatically applied using implantable cardioverter defibrillators (ICDs) and offer the potential for painless termination of ventricular tachycardia (VT). Reduction in ...

An automated implantable cardioverter defibrillator (ICD or AICD) is a permanent device in which a lead (wire) inserts into the right ventricle and monitors the heart rhythm. It is implanted ...

FLINT, Mich. (WNEM) - A mid-Michigan hospital has become one of the first in the country to successfully implant a next-generation cardioverter-defibrillator for patients with dangerously fast or ...

Kestra Medical recently filed a form S-1 to confirm its intent to go public through an initial public offering (IPO).

Cardioverter defibrillators are small battery-powered devices implanted in the chest. They are designed to detect irregular heartbeats and deliver electric shocks to restore the heart’s regular ...

Kestra Medical Technologies announced today that it appointed Al Ford as its new chief commercial officer (CCO).

The first cardioverter-defibrillator, invented and developed by Polish-born Israeli-American physician Michel Mirowski, was implanted in a patient at Johns Hopkins Hospital. Since then ...

How are patients with myocardial scar after a myocardial infarction and ventricular tachycardia currently managed? Implantable cardioverter–defibrillators (ICDs) improve survival in patients ...